HuGE Literature Finder
Records
1
-
30
| Integrative genomic and transcriptomic analysis reveals immune subtypes and prognostic markers in ovarian clear cell carcinoma. British journal of cancer 2022 Jan . Ye Shuang, Li Qin, Wu Yutuan, Jiang Wei, Zhou Shuling, Zhou Xiaoyan, Yang Wentao, Tu Xiaoyu, Shan Boer, Huang Shenglin, Yang Huiju |
| Identification and clinical significance of somatic oncogenic mutations in epithelial ovarian cancer. Journal of ovarian research 2021 Oct 14 (1): 129. Watanabe Takafumi, Nanamiya Hideaki, Endo Yuta, Kojima Manabu, Nomura Shinji, Furukawa Shigenori, Soeda Shu, Tamura Hirosumi, Ryufuku Masae, Tanaka Daisuke, Isogai Takao, Imai Jun-Ichi, Watanabe Shinya, Fujimori Kei |
| Correlation between SNPs of PIK3CA, ERBB2 3'UTR, and their interactions with environmental factors and the risk of epithelial ovarian cancer. Journal of assisted reproduction and genetics 2021 Apr . Chen Haibo, Zhai Zhenyuan, Xie Qinghai, Lai Yuanbin, Chen Guipi |
| Comprehensive Gene Mutation Profiling of Circulating Tumor DNA in Ovarian Cancer: Its Pathological and Prognostic Impact. Cancers 2020 Nov 12 (11): . Noguchi Tomoko, Iwahashi Naoyuki, Sakai Kazuko, Matsuda Kaho, Matsukawa Hitomi, Toujima Saori, Nishio Kazuto, Ino Kazuhi |
| Comparison of BRCA versus non-BRCA germline mutations and associated somatic mutation profiles in patients with unselected breast cancer. Aging 2020 Feb 12 . Chen Bo, Zhang Guochun, Li Xuerui, Ren Chongyang, Wang Yulei, Li Kai, Mok Hsiaopei, Cao Li, Wen Lingzhu, Jia Minghan, Li Cheukfai, Guo Liping, Wei Guangnan, Lin Jiali, Li Yingzi, Zhang Yuchen, Han-Zhang Han, Liu Jing, Lizaso Analyn, Liao Ni |
| Therapeutic options for mucinous ovarian carcinoma. Gynecologic oncology 2020 Jan . Gorringe Kylie L, Cheasley Dane, Wakefield Matthew J, Ryland Georgina L, Allan Prue E, Alsop Kathryn, Amarasinghe Kaushalya C, Ananda Sumitra, Bowtell David D L, Christie Michael, Chiew Yoke-Eng, Churchman Michael, DeFazio Anna, Fereday Sian, Gilks C Blake, Gourley Charlie, Hadley Alison M, Hendley Joy, Hunter Sally M, Kaufmann Scott H, Kennedy Catherine J, Köbel Martin, Le Page Cecile, Li Jason, Lupat Richard, McNally Orla M, McAlpine Jessica N, Pyman Jan, Rowley Simone M, Salazar Carolina, Saunders Hugo, Semple Timothy, Stephens Andrew N, Thio Niko, Torres Michelle C, Traficante Nadia, Zethoven Magnus, Antill Yoland C, Campbell Ian G, Scott Clare |
| MassArray analysis of genomic susceptibility variants in ovarian cancer. Scientific reports 2020 12 10 (1): 21101. Verma Sonali, Sharma Indu, Sharma Varun, Bhat Amrita, Shah Ruchi, Bhat Gh Rasool, Sharma Bhanu, Bakshi Divya, Nagpal Ashna, Wakhloo Ajay, Bhat Audesh, Kumar Rake |
| Identification of novel mutations of ovarian cancer-related genes from RNA-sequencing data for Japanese epithelial ovarian cancer patients. Endocrine journal 2019 Nov . Nagasawa Saya, Ikeda Kazuhiro, Horie-Inoue Kuniko, Sato Sho, Takeda Satoru, Hasegawa Kosei, Inoue Satos |
| Different mutation profiles between epithelium and stroma in endometriosis and normal endometrium. Human reproduction (Oxford, England) 2019 Oct 34 (10): 1899-1905. Suda Kazuaki, Nakaoka Hirofumi, Yoshihara Kosuke, Ishiguro Tatsuya, Adachi Sosuke, Kase Hiroaki, Motoyama Teiichi, Inoue Ituro, Enomoto Takayu |
| Liquid biopsy-based comprehensive gene mutation profiling for gynecological cancer using CAncer Personalized Profiling by deep Sequencing. Scientific reports 2019 Jul 9 (1): 10426. Iwahashi Naoyuki, Sakai Kazuko, Noguchi Tomoko, Yahata Tamaki, Matsukawa Hitomi, Toujima Saori, Nishio Kazuto, Ino Kazuhi |
| Single nucleotide polymorphism of PIK3CA and its interaction with the environment are risk factors for Chinese Han ovarian cancer. Pathology, research and practice 2019 Jun 152520. Zhang Hui, Zhou |
| Loss of 1p36.33 Frequent in Low-Grade Serous Ovarian Cancer. Neoplasia (New York, N.Y.) 2019 May 21 (6): 582-590. Van Nieuwenhuysen Els, Busschaert Pieter, Laenen Annouschka, Moerman Philippe, Han Sileny N, Neven Patrick, Lambrechts Diether, Vergote Igna |
| Survival Following Chemotherapy in Ovarian Clear Cell Carcinoma Is Not Associated with Pathological Misclassification of Tumor Histotype. Clinical cancer research : an official journal of the American Association for Cancer Research 2019 Apr . Takenaka Masataka, Köbel Martin, Garsed Dale W, Fereday Sian, Pandey Ahwan, Etemadmoghadam Dariush, Hendley Joy, Kawabata Ayako, Noguchi Daito, Yanaihara Nozomu, Takahashi Hiroyuki, Kiyokawa Takako, Ikegami Masahiro, Takano Hirokuni, Isonishi Seiji, Ochiai Kazuhiko, Traficante Nadia, Gadipally Sreeja R, Semple Timothy, Vassiliadis Dane, Amarasinghe Kaushalya Christmalee, Li Jason, Mir Arnau Gisela, Okamoto Aikou, Friedlander Michael, Bowtell David D |
| Targeted sequencing of a specific gene panel detects a high frequency of ARID1A and PIK3CA mutations in ovarian clear cell carcinoma. Clinica chimica acta; international journal of clinical chemistry 2019 Mar 494 1-7. Su Yu-Fa, Tsai Eing-Mei, Chen Chih-Chieh, Wu Chun-Chieh, Er Tze-Kio |
| Impact of somatic molecular profiling on clinical trial outcomes in rare epithelial gynecologic cancer patients. Gynecologic oncology 2019 Feb . Rodriguez-Freixinos V, Lheureux S, Mandilaras V, Clarke B, Dhani N C, Mackay H, Butler M O, Wang L, Siu L L, Kamel-Reid S, Stockley T, Bedard P L, Oza A |
| Identification of somatic genetic alterations in ovarian clear cell carcinoma with next generation sequencing. Genes, chromosomes & cancer 2018 02 57 (2): 51-60. Shibuya Yusuke, Tokunaga Hideki, Saito Sakae, Shimokawa Kazurou, Katsuoka Fumiki, Bin Li, Kojima Kaname, Nagasaki Masao, Yamamoto Masayuki, Yaegashi Nobuo, Yasuda J |
| Mutational heterogeneity in non-serous ovarian cancers. Scientific reports 2017 Aug 7 (1): 9728. Teer Jamie K, Yoder Sean, Gjyshi Anxhela, Nicosia Santo V, Zhang Chaomei, Monteiro Alvaro N |
| CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 Oct . Ayhan Ayse, Kuhn Elisabetta, Wu Ren-Chin, Ogawa Hiroshi, Bahadirli-Talbott Asli, Mao Tsui-Lien, Sugimura Haruhiko, Shih Ie-Ming, Wang Tian- |
| A SNaPshot of potentially personalized care: Molecular diagnostics in gynecologic cancer. Gynecologic oncology 2016 Apr 141 (1): 108-12. Penson R T, Sales E, Sullivan L, Borger D R, Krasner C N, Goodman A K, Del Carmen M G, Growdon W B, Schorge J O, Boruta D M, Castro C M, Dizon D S, Birrer M |
| Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer. Journal of molecular medicine (Berlin, Germany) 2016 Feb . Er Tze-Kiong, Su Yu-Fa, Wu Chun-Chieh, Chen Chih-Chieh, Wang Jing, Hsieh Tsung-Hua, Herreros-Villanueva Marta, Chen Wan-Tzu, Chen Yi-Ting, Liu Ta-Chih, Chen Hung-Sheng, Tsai Eing-M |
| Somatic mutations in breast and serous ovarian cancer young patients: a systematic review and meta-analysis. Revista da Associac?a?o Me?dica Brasileira (1992) 2015 Oct 61 (5): 474-83. Encinas Giselly, Maistro Simone, Pasini Fátima Solange, Katayama Maria Lucia Hirata, Brentani Maria Mitzi, Bock Geertruida Hendrika de, Folgueira Maria Aparecida Azevedo Koi |
| Profiling of actionable gene alterations in ovarian cancer by targeted deep sequencing. International journal of oncology 2015 Jun 46 (6): 2389-98. Takenaka Masataka, Saito Motonobu, Iwakawa Reika, Yanaihara Nozomu, Saito Misato, Kato Mamoru, Ichikawa Hitoshi, Shibata Tatsuhiro, Yokota Jun, Okamoto Aikou, Kohno Takas |
| Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms. BMC cancer 2015 15 (1): 415. Mackenzie Robertson, Kommoss Stefan, Winterhoff Boris J, Kipp Benjamin R, Garcia Joaquin J, Voss Jesse, Halling Kevin, Karnezis Anthony, Senz Janine, Yang Winnie, Prigge Elena-Sophie, Reuschenbach Miriam, Doeberitz Magnus Von Knebel, Gilks Blake C, Huntsman David G, Bakkum-Gamez Jamie, McAlpine Jessica N, Anglesio Michael |
| Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma. Virchows Archiv : an international journal of pathology 2014 Aug 465 (2): 193-8. Zannoni Gian Franco, Improta Giuseppina, Chiarello Gaia, Pettinato Angela, Petrillo Marco, Scollo Paolo, Scambia Giovanni, Fraggetta Filip |
| Anastrozole and everolimus in advanced gynecologic and breast malignancies: activity and molecular alterations in the PI3K/AKT/mTOR pathway. Oncotarget 2014 May 5 (10): 3029-38. Wheler Jennifer J, Moulder Stacy L, Naing Aung, Janku Filip, Piha-Paul Sarina A, Falchook Gerald S, Zinner Ralph, Tsimberidou Apostolia M, Fu Siqing, Hong David S, Atkins Johnique T, Yelensky Roman, Stephens Philip J, Kurzrock Razel |
| Distinct molecular profiles in Lynch syndrome-associated and sporadic ovarian carcinomas. International journal of cancer. Journal international du cancer 2013 Dec 133 (11): 2596-608. Niskakoski Anni, Kaur Sippy, Renkonen-Sinisalo Laura, Lassus Heini, Järvinen Heikki J, Mecklin Jukka-Pekka, Bützow Ralf, Peltomäki Päi |
| PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Mar 30 (8): 777-82. Janku Filip, Wheler Jennifer J, Westin Shannon N, Moulder Stacy L, Naing Aung, Tsimberidou Apostolia M, Fu Siqing, Falchook Gerald S, Hong David S, Garrido-Laguna Ignacio, Luthra Rajyalakshmi, Lee J Jack, Lu Karen H, Kurzrock Razel |
| PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors. Molecular cancer therapeutics 2011 Mar 10 (3): 558-65. Janku Filip, Tsimberidou Apostolia M, Garrido-Laguna Ignacio, Wang Xuemei, Luthra Rajyalakshmi, Hong David S, Naing Aung, Falchook Gerald S, Moroney John W, Piha-Paul Sarina A, Wheler Jennifer J, Moulder Stacy L, Fu Siqing, Kurzrock Razel |
| Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer. British journal of cancer 2009 Mar 100 (6): 993-1001. Quaye L, Song H, Ramus S J, Gentry-Maharaj A, Høgdall E, DiCioccio R A, McGuire V, Wu A H, Van Den Berg D J, Pike M C, Wozniak E, Doherty J A, Rossing M A, Ness R B, Moysich K B, Høgdall C, Blaakaer J, , Easton D F, Ponder B A J, Jacobs I J, Menon U, Whittemore A S, Krüger-Kjaer S, Pearce C L, Pharoah P D P, Gayther S |
| PIK3CA amplification associates with resistance to chemotherapy in ovarian cancer patients. Cancer biology & therapy 2009 Jan 8 (1): 21-6. Kolasa Iwona K, Rembiszewska Alina, Felisiak Anna, Ziolkowska-Seta Izabela, Murawska Magdalena, Moes Joanna, Timorek Agnieszka, Dansonka-Mieszkowska Agnieszka, Kupryjanczyk Jolan |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 10, 2022
- Content source: